Anti-ICOS agonist antibodies and uses thereof

METHODS FOR MAKING FULLY HUMAN BISPECIFIC ANTIBODIES USING A COMMON LIGHT CHAIN

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ADAM17 SUBSTRATE DEPENDENT CANCERS

ANTI-CD39 ANTIBODIES

Methods of treatment of CD123 overexpressing disorders

Fc variants with increased affinity for FcγRIIc

IMMUNOGLOBULIN VARIANTS AND USES THEREOF

Anti-human 4-1BB antibodies and uses thereof

Nucleic acid molecules encoding anti-CD40 antibodies

Antibodies against human CSF-1R and uses thereof

Methods And Compositions For Treating And Preventing Disease Associated With Alpha 8 Beta 1 Integrin

Humanized Anti-HLA-DR Antibodies

Anti-human PD-1 humanized monoclonal antibody and application thereof

CD8 binding agents

Human anti-IFN-α antibodies

Human IL-23 Antigen Binding Proteins

Methods of treating cancer using an IL-21 agonist

TGFβ1-binding immunoglobulins and use thereof

Anti-transthyretin antibodies

Neutralizing antibodies to Ebola virus glycoprotein and their use

Polyomavirus neutralizing antibodies

Antibody-drug conjugates and uses thereof

Antibodies against CD73 and uses thereof

Antibodies specific for DR5 and methods of use

ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES

Anti-GITR antibodies and methods of use thereof

FULLY HUMAN ANTIBODIES AGAINST HUMAN 4-1BB

Anti-PrP antibodies and uses thereof

Antigen binding proteins that bind CCR2

ST2L antagonists and methods of use

CD131 binding proteins

Bivalent bispecific antibody hybrid protein expression and preparation methods

Methods of use of anti-Sortilin antibodies for treating a disease, disorder, or injury

Anti-B7-H4 antibodies and immunoconjugates

Immunological reagents

Anti-Siglec-9 antibodies and methods of use thereof

TM4SF1 binding proteins and methods of using same

VEGF/DLL4 BINDING AGENTS AND USES THEREOF

Antagonists of IL17C for the treatment of inflammatory disorders

Antibodies recognizing alpha-synuclein

Antibodies for treatment and diagnosis of inflammatory bowel disease

Nucleic acids encoding anti-C5 antibodies

MRKA POLYPEPTIDES, ANTIBODIES, AND USES THEREOF

Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use

Agents for influenza neutralization

Composition for overcoming resistance to EGFR-targeting agent

Glycoengineered antibody drug conjugates

Antigen binding proteins that bind PD-L1

Fully human anti-C-X-C chemokine receptor 3 (CXCR3) antibodies and methods of use thereof

Method for generating high affinity, bivalent binding agents for sandwich assays

PcrV binding single variable domain antibodies

ANTIBODIES AGAINST CD73 AND USES THEREOF

Anti-mesothelin binding proteins

Multispecific NK engager protein

Anti-CD137 molecules and use thereof

ANTIBODIES AGAINST G-CSFR AND USES THEREOF

Binding members to PD-L1

Fusion proteins and their related methods

TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BY INTRANASAL ADMINISTRATION OF IMMUNOGLOBULIN G

Anti-tenascin C antibodies and uses thereof

Antibody targeting cell surface deposited complement protein C3d and use thereof

Binding moieties for biofilm remediation

ENGINEERED HIGH-AFFINITY HUMAN T CELL RECEPTORS

FORMULATION OF HUMAN ANTIBODIES FOR TREATING TNF-ALPHA ASSOCIATED DISORDERS

IGF-1R antibody and its use for the diagnosis of cancer

Anti-HtrA1 antibodies and methods of use thereof

Anti-CTLA-4 antibodies and uses thereof

Multispecific NK engager protein

Antibody therapeutics that bind CD38

Agents binding specifically to human cadherin-17, human cadherin-5, human cadherin-6 and human cadherin-20 RGD motif

Antagonistic Antibodies Specifically Binding Human CD40 and Methods of Use

Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2)

Bispecific coupled antibody, preparation method and application thereof

Engineered antibody Fc variants for enhanced serum half life

Method for treating pathological angiogenesis by administering an antibody that inhibits APLNR

ANTIBODIES FOR IL-17C

HUMAN ANTIBODIES THAT BIND HUMAN TNF-ALPHA AND METHODS OF PREPARING THE SAME

Broadly neutralizing anti-HIV-1 antibodies that bind to an N-glycan epitope on the envelope

Human antibodies to Ebola virus glycoprotein

Antibody against glypican-3 and application thereof

DLL3 MODULATORS AND METHODS OF USE

Cadherin-17 specific antibodies and cytotoxic cells for cancer treatment

Antibodies which specifically bind αKlotho polypeptide

Ion concentration-dependent binding molecule library

ANTI-TNF- / ANTI-IL-23 IgG BISPECIFIC ANTIBODIES

FGF21 mimetic antibodies and uses thereof

BCMA monoclonal antibody-drug conjugate

Immunoconjugate and uses thereof

Motile Sperm Domain Containing Protein 2 and Cancer

PD-1 antibodies

POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS

Frizzled5 protein-binding agents

Binding molecules specific for HER3 and uses thereof

METHODS OF SCREENING FOR MULTISPECIFIC ANTIBODIES

Anti-PD-1 monoclonal antibody

ANTI-LAG-3 ANTIBODIES

CD3-binding molecules capable of binding to human and non-human CD3

Anti-ROR1 antibodies and uses thereof

Anti-CD33 antibodies and methods of use thereof

Anti-TREM2 antibodies and methods of use thereof

Anti P2Xreceptor antibodies and fragments thereof

Nucleic acids encoding lectin-like oxidized LDL receptor 1 antibodies

Antibodies for the treatment of cancers

USES AND COMPOSITIONS FOR TREATMENT OF ANKLOSING SPONDYLITIS

Common light chain mouse

RSV-specific binding molecule

Method for producing antibody

Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of infections

Use of IL-31 monoclonal antibodies for treating pruritus

RODENTS HAVING AN ENGINEERED HEAVY CHAIN DIVERSITY REGION

T CELL ACTIVATING BISPECIFIC ANTIGEN BINDING MOLECULES

ANTI-DLL4/VEGF DUAL VARIABLE DOMAIN IMMUNOGLOBULIN AND USES THEREOF

Antibody molecules to CD73 and uses thereof

Methods of engineering surface charge for bispecific antibody production

Antibody against EGFRvIII and use thereof

ASPGR ANTIBODIES AND USES THEREOF

CHIMERIC ANTIGEN RECEPTORS AND METHODS OF THEIR USE

ROR2 antibody compositions and related methods

Method of treatment with humanized anti-IL-18 antibodies

Method for Producing Antibodies

EGFL6 specific monoclonal antibodies and methods of their use

Polynucleotides encoding optimized variants of anti-VEGF antibodies

Single domain serum albumin binding protein

HUMANIZED ANTIBODY IGG1

Treating headache comprising administering an antibody to calcitonin gene-related peptide

Human Antibodies to Respiratory Syncytial Virus F Protein and Methods of Use Thereof

Generating multispecific antibody mixtures and methods of uses thereof

Methods for improving safety of blood-brain barrier transport

Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same

Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy

Bispecific antibodies having constant region mutations and uses therefor

Molecules that bind prostate specific membrane antigen (PSMA)

CAMELID HEMOGLOBIN ANTIBODIES AND METHODS OF USE

Methods of using antibodies to detect folate receptor 1 (FOLR1)

Anti-Jagged1 antigen binding proteins

Methods for inducing or enhancing an immune response by administering agonistic glucocorticoid-induced TNFR-family-related receptor (GITR) antibodies

ACTRIIB BINDING AGENTS AND USES THEREOF

Biological materials related to HER3

Anti-PD-L1 nanobody and use thereof

PD-1 antibodies

Anti-CD8 antibodies and uses thereof

Agents, uses and methods for treatment

Humanized, mouse or chimeric anti-CD47 monoclonal antibodies

METHOD OF TREATING CANCER

THERAPEUTIC DRUG FOR MALIGNANT TUMORS

ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF ORAL MUCOSITIS

Nucleic acid molecules encoding monoclonal antibodies specific for IL-17F

ANTIBODIES TO HUMAN GDF8

DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT

Methods and compositions for targeting polyubiquitin

Compositions and methods for reducing at least one symptom of human allergy to cats

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

Rabies virus G protein epitope, and rabies virus neutralising binding molecule that binds specifically thereto

COMMON LIGHT CHAIN MOUSE

Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms

DIRECT AFFINITY MEASUREMENT OF HUMAN IGG1 BINDING MULTIMERIC ANTIGENS

METHOD FOR DETERMINING THE IN VIVO INTERACTION MODE

ANTI-HtrA1 ANTIBODIES AND METHODS OF USE

PCSK9 antibody, antigen-binding fragment thereof, and medical application thereof

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

Anti-CD3 antibodies and methods of use

Self-crosslinking antibodies

Oncofetal antigen binding proteins and related compositions and methods

ANTI-ENDOGLIN ANTIBODIES AND USES THEREOF

Activatable anti-PDL1 antibodies, and methods of use thereof

Antibody against a complex between human GARP and latent TGF-β

CXCR2 antibodies and uses thereof

ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE

Anti-PD-1 antibodies and uses thereof

Antibody constructs for CDH19 and CD3

Antibodies binding LAG-3 and uses thereof

Human programmed cell death 1 receptor antibody, method of preparing same, and use thereof

Immune-stimulating humanized monoclonal antibodies against human interleukin-2, and fusion proteins thereof

COMBINATION THERAPY COMPRISING A SUPERAGONISTIC ANTIBODY AGAINST INTERLEUKIN-2 AND A CHECKPOINT BLOCKADE AGENT

INHIBITION OF ALLERGIC REACTION USING AN IL-33 INHIBITOR

Compound targeting IL-23A and TNF-alpha and uses thereof

FC-REGION VARIANTS WITH MODIFIED FCRN-BINDING PROPERTIES

Antibodies to surface determinants

Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein

Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains

Influenza virus vaccines and uses thereof

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody

ANTIBODY THERAPEUTICS THAT BIND PSMA

Anti-cancer fusion polypeptide

Therapeutic antibodies and uses thereof

Antibodies for treatment of cancer expressing claudin 6

Binding agents

Anti-GITR antibodies and methods of use thereof

Anti-PD-L1 antibodies and uses thereof

ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-LRP5 ANTIBODIES AND METHODS OF USE

Humanized anti-human epidermal growth factor receptor antibody and application thereof

Anti-adrenomedullin (ADM) monoclonal antibodies and anti-ADM monoclonal antibody fragments that bind to adrenomedullin

Antagonists of IL-6 to raise albumin and/or lower CRP

Antagonists of IL-6 to prevent or treat thrombosis

Conditionally active chimeric antigen receptors for modified t-cells

Conditionally Active Chimeric Antigen Receptors for Modified T-Cells

BCMA ANTIGEN BINDING PROTEINS

Interleukin-13 binding proteins

Monoclonal antibody inhibitor of factor XIIA

Anti-EpCAM antibodies, compositions comprising anti-EpCAM antibodies and methods of making and using anti-EpCAM antibodies

Humanized monoclonal antibody specific to syndecan-1

Antibody therapeutics that bind CD123

BISPECIFIC FC MOLECULES

Bispecific T cell activating antigen binding molecules

Bispecific T cell activating antigen binding molecules

Bispecific Monovalent Diabodies That are Capable of Binding B7-H3 and CD3, and Uses Thereof

Caninized antibodies

Anti-CD33 antibodies and methods of use thereof

Antibodies specific for Trop-2 and their uses

ANTIGEN-BINDING PROTEINS TO MARINOBUFAGENIN

Methods of treating a crystal induced arthropathy using IL-1beta antibodies

Anti-GM-CSF antibodies and uses thereof

Anti-myostatin antibodies and methods of use

METHODS AND COMPOSITIONS FOR BINDING VEGF

Broadly neutralizing antibodies against HIV-1 and use thereof

HA binding agents

Polyomavirus neutralizing antibodies

Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof

ANTIBODY AND ANTIBODY MIMETIC FOR VISUALIZATION AND ABLATION OF ENDOGENOUS PROTEINS

Antibody specific to , therapeutic method and detection method using same

NSP4 inhibitors and methods of use

Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease

Deimmunized Serum-Binding Domains and Their Use in Extending Serum Half-Life

ANTIBODIES AGAINST IMMUNOGENIC GLYCOPEPTIDES, COMPOSITIONS COMPRISING THE SAME AND USE THEREOF

Anti-Jagged1 antibodies and methods of use

Anti-Axl antibodies

Hybridoma clones, monoclonal antibodies to VSIG-4, and methods of making and using

Gene signatures for determining ICOS expression

Antibodies comprising chimeric constant domains

Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Multispecific antibodies that target HIV GP120 and CD3

Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor

Anti-TIGIT antibodies

Modulators

Anti-human IL-3 antibodies, their use in treatment of a disease or malfunction associated with elevated expression or levels of IL-3, and their use in a method to detect human IL-3

Stable and soluble antibodies inhibiting TNFα

Anti-activin A antibodies and uses thereof

Therapeutic DLL4 Binding Proteins

Anti-laminin4 antibodies specific for LG4-5

HUMANIZED ANTI-TAU ANTIBODIES

Human anti-alpha-synuclein antibodies

Human cytomegalovirus neutralizing antibodies and use thereof

PEPTIDES OF PAGE5

PEPTIDES

Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen

ROR1 antibody immunoconjugates

LGR4 specific monoclonal antibodies and methods of their use

Anti-LAG3 antibodies and antigen-binding fragments

Targeting of ligand binding sites in ClfA

Transgenic mice

Haemorrhagic disorder due to ventricular assist device

ADAM6 mice

Anti-HER2 glycoantibodies and uses thereof

Anti-coagulation factor XI antibodies

ESOPHAGEAL CANCER MARKER AND USE THEREOF

Single variable domain antibodies against OX40L, constructs and therapeutic use

IL2R common gamma chain antibodies

ANTI-BLOOD DENDRITIC CELL ANTIGEN 2 ANTIBODIES AND USES THEREOF

ANTI-CD33 ANTIBODIES AND METHOD FOR TREATMENT OF ACUTE MYELOID LEUKEMIA USING THE SAME

Human PAC1 antibodies

Anti-GM-CSF antibodies and uses thereof

Pan-ELR+ CXC chemokine antibodies

ANTI-NGF ANTIBODIES AND THEIR USE

Anti-malarial antibodies that bind circumsporozoite protein

Humanized pertussis antibodies and used thereof

HUMANIZED ANTI-EBOLA VIRUS GLYCOPROTEIN ANTIBODIES AND METHODS OF USE

Antigen binding dimer-complexes, methods of making/avoiding and uses thereof

Therapeutic biologic for treatment of hepatocellular carcinoma

IMMUNOMODULATORY PROTEINS

ANTIBODY-DRUG CONJUGATE HAVING IMPROVED STABILITY AND USE THEREOF

NOVEL IMMUNOGLOBULIN VARIANTS

Immunogenic construct comprising an EBV-cell antigen and a targeting moiety and applications thereof

TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS

Chimeric antigen receptors targeting B-cell maturation antigen and uses thereof

ANTI-CD47 ANTIBODIES AND METHODS OF USE THEREOF

Production of T cell retargeting hetero-dimeric immunoglobulins

Method employing bispecific protein complex

Anti-GCC antibody molecules and related compositions and methods

Antibodies that specifically bind PD-1 and methods of use

Anti-PCSK9 antibodies and uses thereof

Anti-factor XI monoclonal antibodies and methods of use thereof

FACTOR XI ANTIBODIES AND METHODS OF USE

Anti-GITR antibodies and methods of use thereof

Polypeptides inhibiting CD40L

Method of detection of IL1RAP on cells expressing the protein

Methods of use of anti-CD123 antibodies and antigen-binding fragments thereof

Anti-TrkB antibodies

Antibodies which specifically bind fibroblast growth factor receptor 1, encoding nucleic acids thereof, and methods of producing thereof

Antibodies Specifically Binding HLA-DR and Their Uses

Antibodies to ICOS

Anti-TIGIT antibodies and methods of use thereof

Optimized Anti-CD3 Bispecific Antibodies and Uses Thereof

Variable regions for NKp46 binding proteins

Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof

TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

Compositions and methods for internalizing enzymes

Ferritin nanoparticle compositions and methods to modulate cell activity

Therapeutic antibodies against ROR-1 protein and methods for use of same